• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素原评估在 SARS-CoV-2 感染中的抗菌药物管理贡献:一项回顾性队列研究。

Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.

机构信息

Department of Microbiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

出版信息

J Hosp Infect. 2021 Apr;110:103-107. doi: 10.1016/j.jhin.2021.01.006. Epub 2021 Jan 20.

DOI:10.1016/j.jhin.2021.01.006
PMID:33484783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7817391/
Abstract

It can be a diagnostic challenge to identify patients with coronavirus disease 2019 in whom antibiotics can be safely withheld. This study evaluated the effectiveness of a guideline implemented at Sheffield Teaching Hospitals NHS Foundation Trust that recommends withholding antibiotics in patients with low serum procalcitonin (PCT), defined as ≤0.25 ng/mL. Results showed reduced antibiotic consumption in patients with PCT ≤0.25 ng/mL with no increase in mortality, alongside a reduction in subsequent carbapenem prescriptions during admission. The results support the effectiveness of this guideline, and further research is recommended to identify the optimal cut-off value for PCT in this setting.

摘要

在确定哪些新冠肺炎患者可以安全停用抗生素时,这可能是一个诊断上的挑战。本研究评估了谢菲尔德教学医院 NHS 基金会信托实施的一项指南的有效性,该指南建议将血清降钙素原 (PCT) 水平低的患者(定义为≤0.25ng/mL)的抗生素停用。结果表明,PCT ≤0.25ng/mL 的患者的抗生素使用量减少,而死亡率没有增加,同时入院期间碳青霉烯类药物的后续处方减少。结果支持该指南的有效性,建议进一步研究以确定该情况下 PCT 的最佳截断值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c5/7817391/90d5bb36edbd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c5/7817391/90d5bb36edbd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52c5/7817391/90d5bb36edbd/gr1_lrg.jpg

相似文献

1
Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.降钙素原评估在 SARS-CoV-2 感染中的抗菌药物管理贡献:一项回顾性队列研究。
J Hosp Infect. 2021 Apr;110:103-107. doi: 10.1016/j.jhin.2021.01.006. Epub 2021 Jan 20.
2
Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.抗生素管理:基于降钙素原水平的 COVID-19 肺炎抗生素的早期停药。
J Clin Pharm Ther. 2022 Feb;47(2):243-247. doi: 10.1111/jcpt.13554. Epub 2021 Nov 11.
3
Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?降钙素原作为 COVID-19 患者呼吸机相关性肺炎的生物标志物:它是一种有用的管理工具吗?
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115344. doi: 10.1016/j.diagmicrobio.2021.115344. Epub 2021 Feb 12.
4
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.探讨降钙素原测定在 COVID-19 中的作用:一项针对住院患者的选定队列研究。
Clin Chem Lab Med. 2020 Nov 19;59(2):433-440. doi: 10.1515/cclm-2020-1361.
5
Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study.降钙素原指导 COVID-19 患者抗生素处方:一项多中心观察性队列研究。
Chest. 2023 Sep;164(3):596-605. doi: 10.1016/j.chest.2023.04.032. Epub 2023 Apr 26.
6
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.苏格兰医院疑似和确诊 COVID-19 患者的抗生素和抗真菌药物处方调查。
J Infect. 2020 Dec;81(6):952-960. doi: 10.1016/j.jinf.2020.09.024. Epub 2020 Sep 26.
7
Combining Procalcitonin and Rapid Multiplex Respiratory Virus Testing for Antibiotic Stewardship in Older Adult Patients With Severe Acute Respiratory Infection.降钙素原与快速多重呼吸道病毒检测联合用于老年重症急性呼吸道感染患者的抗生素管理。
J Am Med Dir Assoc. 2020 Jan;21(1):62-67. doi: 10.1016/j.jamda.2019.09.020. Epub 2019 Nov 30.
8
Embracing Procalcitonin for Antimicrobial Stewardship.采用降钙素原进行抗菌药物管理。
J Appl Lab Med. 2019 Jan;3(4):712-715. doi: 10.1373/jalm.2018.026385. Epub 2018 Nov 20.
9
Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19.降钙素原在 COVID-19 住院癌症患者中的抗菌药物管理作用。
Elife. 2022 Dec 21;11:e81151. doi: 10.7554/eLife.81151.
10
Hospital physicians' experiences with procalcitonin - implications for antimicrobial stewardship; a qualitative study.医院医生使用降钙素原的经验-对抗菌药物管理的启示;一项定性研究。
BMC Infect Dis. 2020 Jul 16;20(1):515. doi: 10.1186/s12879-020-05246-6.

引用本文的文献

1
Procalcitonin Level and Antimicrobial Resistance among Microbial Coinfection in Hospitalized COVID-19 Patients.住院COVID-19患者微生物合并感染中的降钙素原水平与抗菌药物耐药性
Rep Biochem Mol Biol. 2025 Jan;13(4):474-483. doi: 10.61186/rbmb.13.4.474.
2
Utility of Procalcitonin in Clinical Practice.降钙素原在临床实践中的应用价值。
J Brown Hosp Med. 2023 Jul 1;2(3):81280. doi: 10.56305/001c.81280. eCollection 2023.
3
Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19? A scoping review.

本文引用的文献

1
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.苏格兰医院疑似和确诊 COVID-19 患者的抗生素和抗真菌药物处方调查。
J Infect. 2020 Dec;81(6):952-960. doi: 10.1016/j.jinf.2020.09.024. Epub 2020 Sep 26.
2
Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.采用双靶点E和RdRp检测法提高SARS-CoV-2感染诊断的敏感性:英国一家大型国民保健服务基金会信托机构的经验。
J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.061. Epub 2020 May 28.
3
C反应蛋白和降钙素原对COVID-19患者进行抗菌药物管理而言安全且有用吗?一项范围综述。
Antimicrob Steward Healthc Epidemiol. 2024 Sep 12;4(1):e129. doi: 10.1017/ash.2024.372. eCollection 2024.
4
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19.回顾性倾向评分匹配队列研究:降钙素原检测对 COVID-19 第一波期间住院患者抗生素使用的影响。
J Antimicrob Chemother. 2024 Nov 4;79(11):2792-2800. doi: 10.1093/jac/dkae246.
5
The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study.降钙素原指导 COVID-19 住院患者使用抗生素的成本效益:PEACH 研究的一部分。
J Antimicrob Chemother. 2024 Aug 1;79(8):1831-1842. doi: 10.1093/jac/dkae167.
6
Role of biomarkers in antimicrobial stewardship: physicians' perspectives.生物标志物在抗菌药物管理中的作用:医生的观点。
Korean J Intern Med. 2024 May;39(3):413-429. doi: 10.3904/kjim.2023.558. Epub 2024 Apr 30.
7
Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).在 COVID-19 大流行的第一波期间,为 NHS 急性医院中患有 COVID-19 肺炎的患者制定抗生素处方决策模型:降钙素评估 COVID-19 住院患者抗生素使用情况(PEACH 研究)的定性结果。
BMJ Open. 2023 Dec 19;13(12):e077117. doi: 10.1136/bmjopen-2023-077117.
8
[Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy].[危重症 COVID-19 患者的细菌合并感染:发生率、影响及抗菌治疗需求]
Rev Esp Quimioter. 2023 Dec;36(6):612-620. doi: 10.37201/req/060.2023. Epub 2023 Sep 25.
9
Procalcitonin Values Fail to Track the Presence of Secondary Bacterial Infections in COVID-19 ICU Patients.降钙素原水平无法追踪COVID-19重症监护病房患者继发性细菌感染的存在情况。
Antibiotics (Basel). 2023 Apr 5;12(4):709. doi: 10.3390/antibiotics12040709.
10
Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review.COVID-19 大流行前后急性护理环境中抗菌药物管理的实施:系统评价。
BMC Public Health. 2023 Feb 10;23(1):309. doi: 10.1186/s12889-023-15072-5.
Co-infections in people with COVID-19: a systematic review and meta-analysis.
COVID-19 患者合并感染:系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
4
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
5
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
6
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.与 2019 年冠状病毒病(COVID-19)严重疾病和死亡相关的血液学、生物化学和免疫生物标志物异常:荟萃分析。
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Special considerations of antibiotic prescription in the geriatric population.老年人抗生素处方的特殊考虑因素。
Clin Microbiol Infect. 2015 Jan;21(1):3-9. doi: 10.1016/j.cmi.2014.08.018. Epub 2014 Oct 13.
9
Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey.降钙素原算法在研究条件外指导呼吸道感染抗生素治疗的效果:一项研究后调查。
Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):269-77. doi: 10.1007/s10096-009-0851-0. Epub 2009 Dec 29.